Masimo Corporation
MASI
株式のランク
#2164
Masimo Corporation engages in the development, manufacture, and marketing of... Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
株価
$179.95
最終同期: 2026-06-12
時価総額
$9.42B
変化（1日）
0.00%
変化（1年）
22.41%
国
US
取引 Masimo Corporation (MASI)
カテゴリー
Healthcare
Masimo Corporation（MASI）の利益
Apr 2026 時点の利益 TTM: $275.60M
Masimo Corporation の最新の財務報告によると、同社の現在の利益は $275.60M です。2023 年には $88.10M の利益を上げ、これは 2022 年の利益 $193.40M と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Masimo Corporation の利益の推移（2002 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $275.60M | -190.27% |
| 2024 | $-305.30M | -446.54% |
| 2023 | $88.10M | -54.45% |
| 2022 | $193.40M | -29.52% |
| 2021 | $274.40M | 4.06% |
| 2020 | $263.70M | 12.61% |
| 2019 | $234.17M | 9.54% |
| 2018 | $213.78M | 15.06% |
| 2017 | $185.80M | -57.14% |
| 2016 | $433.52M | 272.61% |
| 2015 | $116.35M | 14.02% |
| 2014 | $102.04M | 34.75% |
| 2013 | $75.73M | -9.66% |
| 2012 | $83.82M | -3.13% |
| 2011 | $86.53M | -19.56% |
| 2010 | $107.57M | 30.89% |
| 2009 | $82.18M | 13.52% |
| 2008 | $72.39M | 6.27% |
| 2007 | $68.12M | -78.33% |
| 2006 | $314.40M | 4,166.56% |
| 2005 | $7.37M | 0.00% |
| 2004 | 0.00 | -100.00% |
| 2003 | $-6.89M | 3,707.73% |
| 2002 | $-181.00K | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $7.51B | 2,625.33% |
US
|
|
| $5.56B | 1,918.51% |
IE
|
|
| $5.15B | 1,767.92% |
US
|
|
| $3.86B | 1,300.94% |
US
|
|
| - | - |
DE
|
